ArticleScientific reports2025
Preclinical dose assessment of cyberknife with small animal intracranial irradiation using a 3D printed mouse phantom.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Dose verification in preclinical CyberKnife-based stereotactic radiosurgery (CK-SRS) of intracranial tumors is complicated by the unique characteristics of the system, including its highly conformal, non-coplanar radiation delivery and small-field irradiation. This raises concerns about the reliability of dosimetric measurements in CK-SRS radiobiological studies, emphasizing the need for standardized dosimetry protocols to improve dose accuracy and reproducibility. This study aims to evaluate a fully 3D-printed mouse phantom as a tool for preclinical intracranial CK-SRS dose verification. A 3D-printed mouse phantom was fabricated using clear resin and glass-filled polyamide (PA3200 GF) for tissue-bone-equivalent structures and modified to accommodate both EBT3 film and thermoluminescent dosimeters (TLD). Two treatment configurations were employed using CyberKnife M6 system, including two simple static field plans and two complex non-planar plans. The dosimetric evaluation of the mouse phantom involved comparing the mean dose and dose discrepancies between film profile measurements, TLD-derived point-dose readings, and the corresponding doses calculated by the treatment plan system (TPS) for each configuration. Across all measurements for single-beam and non-planer stereotactic treatment configuration, dose values exhibited a deviation of no more than 4.20% from the corresponding TPS calculated data. The 2D dose distributions obtained from the film measurements and those calculated by the TPS were successfully registered. The mean dose differences for lateral profiles showed a high level of agreement, with discrepancies of only 2.23%. Similarly, the agreement was similarly excellent with a mean dose difference of 2.31% along the anteroposterior axes. TLD measurements also displayed comparable agreement with TPS-calculated results, with the maximum dose difference recorded at 2.20% for the single-beam and 4.12% for the non-planar treatment configuration. This study demonstrates the utility of 3D-printed mouse phantom for accurate dose assessment in preclinical intracranial CK-SRS. The phantom serves as an effective tool for pre-treatment dose verification, improving dosimetric precision while offering a cost-efficient solution for radiobiological research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.